OCT 31, 2018 9:02 AM PDT

Cytostatic Drug Proved Potent For Cancer

WRITTEN BY: Nouran Amin

Image via ArcoMed

A study published in journal Angewandte Chemie, describes how a cytostatic drug, consisting of therapeutically active molecules that is linked to specific antibodies can treat tumors. Such novel conjugates are made from antibodies and a protein that inhibits kinesin spindle formation.

The study revealed that changing the “linkage” between these two components allows for the drugs cytostatic activity in a broad palette of cancers.

The purpose of the study was to introduce a new cytostatic drug that will not produce adverse effects on cancer patients. This is especially true since many medications may be effective but interfere with physiological regulatory mechanisms that cause the impairment of immune defenses, produce hair loss, and induce nausea.

Watch the short video below on side-effects of chemotherapeutic drugs:

The study was aimed at introducing a cytostatic drug directly into tumor cells before triggering a toxic effect. One proposed way was to attach small drug molecules to an antibody (that binds to specific sites—antigens) and produce a conjugate.

The linker will serve as a bridging component that will hold the conjugate together for as long as it circulates in the blood. Although incorporating cytostatic drugs into antibody conjugates have been so far successful, they are limited.

Diverging away from the classic mechanisms of cytostatic drugs, researchers have opted to use cytotoxin that which that utilizes a different biological pathway. More specifically, the cytotoxin is a novel pyrrole-based kinesin spindle protein (KSP) inhibitor which is implicated centrosome separation during cell division. Low doses of this cytoxin is highly effective enough to inhibiting this step of the cell cycle leading to a strong antitumor effect. The researchers have demonstrated that use of this technique can produce a highly effective antibody conjugates that allow them to target a variety of tumor types.

Image Credit: Wiley Online Libraries

The developed conjugates were seen to be very potent in vitro and when using experiments on mice, the conjugates led to complete remission of a human bladder tumor model with minimal side effects

Source: Wiley

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
APR 15, 2020
APR 15, 2020
How Magic Mushrooms Restructure the Brain
For some time now, researchers have suspected that psilocybin, the hallucinogen chemical present in ‘magic mushroo ...
APR 21, 2020
Health & Medicine
APR 21, 2020
How to Read COVID-19 News (Without Going Crazy)
  It can feel like COVID-19 news is consuming the country, and taking all the toilet paper and N95-masks with it. N ...
APR 21, 2020
Drug Discovery & Development
APR 21, 2020
Classic Chemotherapeutic Repurposed for Treating Leukemia
Researchers were seeking a promising new strategy to challenge drug resistance in leukemia. They found that targeted low ...
APR 24, 2020
Drug Discovery & Development
APR 24, 2020
Drug Targets Hard To Treat Uterine Cancer
A clinical trial was deemed successful when evaluating a therapeutic for a hard-to-treat form of uterine cancer. The dru ...
MAY 12, 2020
Cannabis Sciences
MAY 12, 2020
Study Shows Cannabis May Block COVID-19 Infection
Researchers from the University of Lethbridge, Canada, have found that cannabis may be able to block COVID-19 infections ...
MAY 23, 2020
MAY 23, 2020
A New Biomarker to Identify a Triple Negative Breast Cancer Prognosis
Breast cancer, one of the most common cancers in the world, are commonly separated into one of several sub-types. These ...
Loading Comments...